-transparent.png){kind=logo}
Amphotericin B (1 mg/kg of body weight, intravenous) and fluconazole (100 mg/kg, intraperitoneal) were compared in the prophylaxis of experimental Candida endocarditis caused by drug-susceptible, non-C. albicans strains C. tropicalis and C. parapsilosis. Neither antifungal agent was effective at preventing endocarditis due to either Candida strain when either agent was administered in a single-dose regimen (1 h prior to fungal challenge); the prophylactic efficacy of both agents increased substantially when a second prophylactic dose was given (24 h postchallenge). The excellent prophylactic efficacy of fluconazole, a fungistatic agent, underscores the importance of microbistatic mechanisms in endocarditis prophylaxis.
A S Bayer, and
M D Witt, and
E Kim, and
M A Ghannoum
January 1996,
Antimicrobial agents and chemotherapy,
A S Bayer, and
M D Witt, and
E Kim, and
M A Ghannoum
January 2013,
Indian journal of medical microbiology,
A S Bayer, and
M D Witt, and
E Kim, and
M A Ghannoum
January 2000,
Diagnostic microbiology and infectious disease,
A S Bayer, and
M D Witt, and
E Kim, and
M A Ghannoum
March 1962,
The New England journal of medicine,
A S Bayer, and
M D Witt, and
E Kim, and
M A Ghannoum
December 1985,
Antimicrobial agents and chemotherapy,
A S Bayer, and
M D Witt, and
E Kim, and
M A Ghannoum
May 2010,
Research in microbiology,
A S Bayer, and
M D Witt, and
E Kim, and
M A Ghannoum
December 1999,
Antimicrobial agents and chemotherapy,
A S Bayer, and
M D Witt, and
E Kim, and
M A Ghannoum
July 2014,
Jundishapur journal of microbiology,
A S Bayer, and
M D Witt, and
E Kim, and
M A Ghannoum
April 1966,
American journal of diseases of children (1960),
A S Bayer, and
M D Witt, and
E Kim, and
M A Ghannoum
October 1992,
Antimicrobial agents and chemotherapy,
